Lee, M. S., Helms, T. L., Feng, N., Gay, J., Chang, Q. E., Tian, F., . . . Kopetz, S. (2016). Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Oncotarget.
Chicago Style CitationLee, Michael S., et al. "Efficacy of the Combination of MEK and CDK4/6 Inhibitors in Vitro and in Vivo in KRAS Mutant Colorectal Cancer Models." Oncotarget 2016.
Cita MLALee, Michael S., et al. "Efficacy of the Combination of MEK and CDK4/6 Inhibitors in Vitro and in Vivo in KRAS Mutant Colorectal Cancer Models." Oncotarget 2016.
Atenció: Aquestes cites poden no estar 100% correctes.